Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2878 Target Snapshot

Histone deacetylase 6 · SINGLE PROTEIN · Mus musculus

157Compounds
89Assays
1Approved Drugs
109.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q9Z2V5. Use UniProt Q9Z2V5 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9Z2V5 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Histone deacetylase 6 as ChEMBL target CHEMBL2878, mapped to UniProt Q9Z2V5. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Histone deacetylase 6
SINGLE PROTEIN · Mus musculus
As of 2026-09-13
ChEMBL target ID
CHEMBL2878
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q9Z2V5
Protein deacetylase HDAC6
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Histone deacetylase 6 is the right protein anchor across sources, using UniProt Q9Z2V5 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProtein deacetylase HDAC6
UniProt AccessionQ9Z2V5
Component TypeProtein
Sequence Length1149 aa

Protein deacetylase HDAC6

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Histone deacetylase 6, mapped to UniProt Q9Z2V5. ChEMBL maps the protein component as Protein deacetylase HDAC6. Sequence length is 1149 aa.

Mapped IDQ9Z2V5
Review nameHistone deacetylase 6
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase I
Assay Mix

Activity Type Distribution

IC50106.0
EC503.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL343448 9.2 IC50 0.625 Approved
CHEMBL99 8.55 IC50 2.8 Preclinical
CHEMBL2018302 8.36 IC50 4.4 Preclinical
CHEMBL394261 8.06 IC50 8.8 Preclinical
CHEMBL4636622 8.01 IC50 9.7 Preclinical
CHEMBL390991 7.92 IC50 12.0 Preclinical
CHEMBL1790587 7.89 IC50 13.0 Preclinical
CHEMBL2158745 7.89 IC50 13.0 Preclinical
CHEMBL379049 7.64 IC50 23.0 Preclinical
CHEMBL241555 7.62 IC50 24.0 Preclinical
Distribution

pChEMBL Value Distribution

4
5.0
6
5.5
25
6.0
22
6.5
24
7.0
12
7.5
3
8.0
1
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ROMIDEPSIN
CHEMBL343448
Approved 2009
Assay Landscape

Assay Landscape

89
Total Assays
80
Tested Compounds
3
Assay Types
Binding — 68 assays, 80 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 57 70 6.9
single protein format 7 10 6.6
assay format 3 0
tissue-based format 1 0
Functional — 20 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 20 0
ADME — 1 assays, 9 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 9 6.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine